Dr. Fabrizio Fazzi

Providing molecular diagnostic product development services at every stage of product development, from project planning to product launch. Responsible for designing and developing singleplex or multiplex real-time PCR assays for the detection of infectious respiratory diseases

Providing scientific and clinical support to opinion leaders and physicians about the clinical application of the company client products for the treatment of fibrotic diseases and supporting clinical trial enrollment

Establishment of animal tumor models and in vivo imaging techniques in the preclinical studies of new therapeutic approaches for cancer diseases

Investigated the role of antioxidant enzymes (superoxide dismutase) in interstitial lung disease and apoptosis associated with pulmonary damage

Identified the TNFR1 trafficking/Phox interaction as a key event in the pathogenesis of silicosis that prevented mitochondrial reactive oxygen species formation and reduced macrophage apoptosis

Acquired expertise in bone marrow mesenchymal stem cell immunodepletion and in stem cell based therapies

Marketing pharmaceutical products and organizing Continuing Medical Education Conferences (CME) for hospital physicians

Providing drug information (drug indications about side effects, features, and benefits) to physicians and organizing and attending sales meetings and training sessions in support of management teams

Role of phospholipids oxidative metabolism in executing the pathway of apoptosis during alveolar macrophages response to environmental agents

Focusing on the biochemistry of food and technology

Synthesis and physicochemical and biological characterization of an iron chelator (3-hydroxy-2-(5-hydroxypentyl)-4H-chromen-4-one)